Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Masimo Corp MASI

Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital... see more

Recent & Breaking News (NDAQ:MASI)

Masimo Stork(TM) Delivers State-of-the-Art Baby Monitoring to the Home

Business Wire May 1, 2023

Masimo to Report First Quarter 2023 Financial Results After Market Close on Tuesday, May 9

Business Wire April 25, 2023

Masimo Announces FDA Clearance of the Rad-G® with Temperature

Business Wire April 18, 2023

Masimo Opioid Halo(TM) Granted De Novo for the First and Only FDA-Authorized Opioid Overdose Prevention and Alert System

Business Wire April 3, 2023

Masimo Unveils the Future of Health Tracking and Smart Wearables with the Pre-Sale Launch of the Freedom(TM) Smartwatch

Business Wire March 28, 2023

Masimo Announces Changes to Governance Structure and Practices

Business Wire March 23, 2023

European Society of Anaesthesiology and Intensive Care (ESAIC) Recommends Noninvasive, Continuous Hemoglobin Monitoring

Business Wire March 15, 2023

New Study Finds That Masimo PVi® Reliably Predicted Fluid Responsiveness in Young Children Undergoing Neurosurgery

Business Wire March 9, 2023

Masimo and Temple Health Form Innovation Collaboration with Focus on Hospital Automation and Telehealth Initiatives

Business Wire March 7, 2023

New Study Evaluates the Use of Masimo PVi® As an Indicator of Fluid Responsiveness to Guide Goal-Directed Fluid Therapy in Adult Neurosurgical Patients

Business Wire March 6, 2023

CalSTRS Joins Politan Capital Management in Legal Action Against Masimo CEO's Employment Agreement

Business Wire March 3, 2023

Masimo to Present in 44th Annual Raymond James Institutional Investors Conference

Business Wire March 2, 2023

Masimo Reports Fourth Quarter and Full-Year 2022 Financial Results

Business Wire February 28, 2023

New Study Evaluates the Utility of Masimo ORi(TM) in Reducing Hyperoxemia During Laparoscopic Gastrectomy

Business Wire February 21, 2023

Masimo Centroid® Receives Innovative Technology Designation from Vizient

Business Wire February 15, 2023

Masimo to Report Fourth Quarter and FY 2022 Financial Results After Market Close on Tuesday, February 28

Business Wire February 14, 2023

Masimo Announces the Limited Market Release of Visual Clinical Activity Monitoring (VCAM(TM))

Business Wire January 30, 2023

Researchers Harness the Power of Masimo Root®'s Advanced Multimodal Monitoring Capabilities to Study the Impact of Different Ventilatory Strategies on Brain Oxygenation During Thoracoscopic Surgery

Business Wire January 23, 2023

Masimo and Philips Expand Partnership to Improve Telehealth for Patients and Clinicians Around the World with the Masimo W1(TM) Watch

Business Wire January 18, 2023

ITC Judge Rules Apple Violated U.S. Trade Laws by Infringing Masimo Pulse Oximeter Patent

Business Wire January 10, 2023